{"id":42096,"date":"2026-08-25T04:43:42","date_gmt":"2026-08-25T02:43:42","guid":{"rendered":"https:\/\/www.abcsg.org\/?page_id=42096"},"modified":"2026-08-25T05:07:43","modified_gmt":"2026-08-25T03:07:43","slug":"abcsg-66-adaptela-overview","status":"publish","type":"page","link":"https:\/\/www.abcsg.org\/en\/abcsg-studien\/studies-open-for-enrollment\/abcsg-66-adaptela\/abcsg-66-adaptela-overview\/","title":{"rendered":"ABCSG 66 \/ ADAPTela Overview"},"content":{"rendered":"<p>ABCSG 66 \/ ADAPTela is a WSG-sponsored, adjuvant, open-label, interventional Phase III clinical trial for a high-risk HR-positive\/HER2-negative early breast cancer patient population, comparing elacestrant with standard of care endocrine treatment (both arms with or without ribociclib). The genomic Oncotype DX\u00ae test is used to determine a specific genomic profile of patients, making it a personalized therapeutic approach to predict treatment benefits in HR-positive\/HER2-negative early breast cancer.<\/p>\n<table class=\"studienmeta-public\">\n<tbody>\n<tr>\n<td>Study Start:<\/td>\n<td>Q2\/2026<\/td>\n<\/tr>\n<tr>\n<td>Coordinating Investigator:<\/td>\n<td>Dr. Christoph Suppan (f\u00fcr AT)<\/td>\n<\/tr>\n<tr>\n<td>Sample size:<\/td>\n<td>1520 (Germany, Spain and Austria)<\/td>\n<\/tr>\n<tr>\n<td>Studien design:<br \/>\n<em>(Click to enlarge)<\/em><\/td>\n<td><a  href=\"https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2026\/08\/image001-1.png\" data-rel=\"lightbox-gallery-0\" data-rl_title=\"\" data-rl_caption=\"\" title=\"\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-42099\" src=\"https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2026\/08\/image001-1-280x94.png\" alt=\"ABCSG 66 \/ ADAPTela Study design\" width=\"280\" height=\"94\" srcset=\"https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2026\/08\/image001-1-280x94.png 280w, https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2026\/08\/image001-1-768x258.png 768w, https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2026\/08\/image001-1.png 966w\" sizes=\"auto, (max-width: 280px) 100vw, 280px\" \/><\/a><\/td>\n<\/tr>\n<tr>\n<td>Sponsor<\/td>\n<td><a href=\"https:\/\/wsg-online.com\/\">WSG<\/a>\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ABCSG 66 \/ ADAPTela is a WSG-sponsored, adjuvant, open-label, interventional Phase III clinical trial for a high-risk HR-positive\/HER2-negative early breast cancer patient population, comparing elacestrant with standard of care endocrine treatment (both arms with or without ribociclib). The genomic Oncotype DX\u00ae test is used to determine a specific genomic profile of patients, making it a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":42093,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-einzel-studie.php","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"tags":[],"class_list":["post-42096","page","type-page","status-publish","hentry"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/42096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/comments?post=42096"}],"version-history":[{"count":3,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/42096\/revisions"}],"predecessor-version":[{"id":42106,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/42096\/revisions\/42106"}],"up":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages\/42093"}],"wp:attachment":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/media?parent=42096"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/tags?post=42096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}